Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | DXCM | ABT |
|---|---|---|
| Price | $85.96 | $97.46 |
| Change today | ▼ 0.38% | ▼ 1.38% |
| Market cap | $32.44B | $168.65B |
| Return, 3 months | – | +6.5% |
| Return, year to date | – | -20.8% |
| Return, 1 year | – | -25.3% |
| P/E (TTM) | 34.0 | 31.5 |
| P/B | 12.4 | 3.3 |
| P/E percentile vs own 5y | 10th | 69th |
| Dividend yield | – | 2.50% |
| Revenue growth (YoY, latest qtr) | +13.1% | +13.0% |
| Net profit growth (YoY) | +38.5% | -47.8% |
| Gross margin | 62.5% | 56.6% |
| Operating margin | 22.9% | 15.8% |
| Net margin | 20.1% | 11.6% |
| Return on equity | 38.5% | 10.7% |
| Analyst target vs. price | +9.1% | +27.6% |
| Analyst buy share | 95% | 100% |
| RSI (14) | – | 30 |
| 30-day volatility | – | 20.3% |
| Max drawdown, 1 year | – | -38.6% |
| Trend read | – | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
